$NBIS

Boynton John Wilson IV sold $1.3M of NBIS

Boynton John Wilson IV sold 6,364 shares of Nebius Group N.V. (NBIS) at an average of $210.36 ($207.67–$216.52, $1.34M total) across 9 trades on 2026-09-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Boynton John Wilson IV
Published Sep 17, 2026, 7:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 7:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NBIS
Neutral
medium confidence
Mentioned
$NBIS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NBISNeutralLow
01

Why it matters

The disclosed sale provides fresh data on insider holdings and may influence short-term trading sentiment.

02

Market read

A director's $1.3M share sale is a modest insider activity that offers limited trading insight.

03

What to watch

Potential upcoming corporate actions or earnings that prompted the pre-arranged sale.

Relevance 5/10Novelty 4/10Timing: filed Sep 17, 2026

Background

Form 4 filing discloses insider transactions; this is the first public report of the sale.

Company-level read

Ticker impact

$NBISNeutralMedium confidence
Context

Director Boynton John Wilson IV sold $1.3M of NBIS shares via a 10b5-1 plan on Sep 15, reducing his stake to 410,832 shares.

Expected impact

Potential modest short-term dip, limited to a few basis points.

Evidence & confidence

A $1.3M sale by a director is material but not large enough to drive significant price movement; market may view it as routine.

Market effects

Minimal impact on the broader sector; insider sales are common and not sector-defining.

Limited to markets where NBIS trades; no broader regional effect.

Low global relevance.

Counterpoint

The sale could be a strategic rebalancing rather than a lack of confidence, suggesting no bearish action needed.

Key entities

  • Nebius Group N.V.

    Issuer of the shares sold.

  • Boynton John Wilson IV

    Director and insider executing the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NBISMed

Nebius stock breaks below $200 as CoreWeave’s debt scare spreads

Nebius Group (NBIS) fell 10.1% to $186.01 on October 14, 2026, breaking its $200 support level. The decline was driven by fears of excessive debt in the AI sector, sparked by CoreWeave (CRWV) bonds yielding near 15%. Nebius's funding costs may rise due to this market sentiment. The company's stock trades at 38x trailing sales and 7x forward sales, with analysts' price targets ranging from $84 to $410.

$NBISMed

Why is Nebius stock sliding today?

Nebius Group NV (NBIS) stock fell 4.1% to $178.4 in pre-open trading, extending losses due to rising borrowing costs, higher bond yields for peer CoreWeave, and Gartner's warning about AI infrastructure spending risks. Insider selling and a bearish stance from short-seller Michael Burry also contributed. The broader tech sector selloff, driven by higher Treasury yields, added pressure.

$NBISMed

Nebius Group (NBIS) Shares Drop 10% Amid Tech Sell-Off; P/S Rati

Nebius Group (NBIS) shares fell 10.08% to $186.01 on October 14, 2026, amid a broader tech sector sell-off. The company's P/S ratio is 38.39, significantly above its historical median and industry norms. Nebius has a GF Score of 52, with strong momentum but weak valuation and financial strength. Insiders have sold $318.2 million in shares over the past year, while some institutional investors have increased their stakes.